Olink®Part of Thermo Fisher Scientific
Powerful, NGS-based proteomics - effortlessly uncover meaningful insights
A unique combination of specificity and scalability enables high-throughput, multiplex protein biomarker analysis.
Next-generation high-throughput proteomics empowers genetically-informed assessment of protein causality and the confident identification of novel drug targets.
Join Olink users, consortia, events and webinars to share insights and accelerate biomarker discovery.
Comprehensive statistical analysis & data visualization tools
Over 4,000 and growing rapidly – covering all major disease areas
Your source for Olink’s terms, privacy policies, and compliance details
Filters
GSC Biological and Pharmaceutical Sciences, 2020Susceptibility of men to SARS-CoV-2 may be caused by sex differences in ACE2 expression
Olink Target 96
Cell Reports Medicine, 2020Systems-Level Immunomonitoring from Acute to Recovery Phase of Severe COVID-19
Rodriguez L., Pekkarinen P., Lakshmikanth T. et al.
Translational Psychiatry, 2020Molecular linkage between post-traumatic stress disorder and cognitive impairment: a targeted proteomics study of World Trade Center responders
Kuan P., Clouston S., Yang X. et al.
Scientific Reports, 2020Using proximity extension proteomics assay to discover novel biomarkers associated with circulating leptin levels in patients with type 2 diabetes
Vavruch C., Nowak C., Feldreich T. et al.
Analytical Biochemistry, 2020The status of proteomics as we enter the 2020s: Towards personalised/precision medicine
Nice E.
American Journal of Reproductive Immunology, 2020First‐trimester trophoblasts obtained by chorionic villus sampling maintain tolerogenic and proteomic features in successful pregnancies despite a history of unexplained recurrent pregnancy loss
Bruno V., Lindau R., Jenmalm M. et al.
Inflammatory Bowel Diseases, 2020Salivary and Serum Inflammatory Profiles Reflect Different Aspects of Inflammatory Bowel Disease Activity
Majster M., Lira-Junior R., Höög C. et al.
Fluids and Barriers of the CNS, 2020Location matters: highly divergent protein levels in samples from different CNS compartments in a clinical trial of rituximab for progressive MS
Bergman J., Svenningsson A., Liv P. et al.
Neuroendocrinology, 2020A Plasma Protein Biomarker Strategy for Detection of Small Intestinal Neuroendocrine Tumors
Kjellman M., Knigge U., Welin S. et al.
European Heart Journal, 2020Improved cardiovascular risk prediction using targeted plasma proteomics in primary prevention
Hoogeveen R., Pereira J., Nurmohamed N. et al.
Kidney International, 2020A profile of multiple circulating tumor necrosis factor receptors associated with early progressive kidney decline in Type 1 Diabetes is similar to profiles in autoimmune disorders
Ihara K., Skupien J., Krolewski B. et al.
Scientific Reports, 2020Identification of TNFAIP3 as relapse biomarker and potential therapeutic target for MOG antibody associated diseases
Saxena S., Lokhande H., Gombolay G. et al.
PLOS ONE, 2020Inflammation, non-endothelial dependent coronary microvascular function and diastolic function—Are they linked?
Suhrs H., Schroder J., Bové K. et al.
Journal of Clinical Medicine, 2020A Phase 2 Clinical Trial on the Use of Cibinetide for the Treatment of Diabetic Macular Edema
Lois N., Gardner E., McFarland M. et al.
Cell Reports, 2020A Patient-Derived Cell Atlas Informs Precision Targeting of Glioblastoma
Johansson P., Krona C., Kundu S. et al.
Heart and Vessels, 2020Elevated plasma endocan and BOC in heart failure patients decrease after heart transplantation in association with improved hemodynamics
Ahmed S., Ahmed A., Bouzina H. et al.
Genome Medicine, 2020Multi-method genome- and epigenome-wide studies of inflammatory protein levels in healthy older adults
Hillary R., Trejo-Banos D., Kousathanas A. et al.
Journal of Internal Medicine, 2020Use of proteomics to identify biomarkers associated with chronic kidney disease and long‐term outcomes in patients with myocardial infarction
Edfors R., Lindhagen L., Spaak J. et al.
Circulation, 2020Genetic Associations With Plasma Angiotensin Converting Enzyme 2 Concentration
Nelson C., Sama I., Codd V. et al.
Biomedicines, 2020Novel Blood-Derived Extracellular Vesicle-Based Biomarkers in Alzheimer’s Disease Identified by Proximity Extension Assay
Ellegaard Nielsen J., Sofie Pedersen K., Vestergård K. et al.
4265 publications
Items per page
3821-3840 of 4265 publications